Xiufeng Hu

1.3k total citations
23 papers, 807 citations indexed

About

Xiufeng Hu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiufeng Hu has authored 23 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Xiufeng Hu's work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (4 papers). Xiufeng Hu is often cited by papers focused on MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (4 papers). Xiufeng Hu collaborates with scholars based in China and United States. Xiufeng Hu's co-authors include Hongbo Wu, Xiaoqian Mu, Yanqiu Zhao, Yu Mu, Audrey Bouillez, Donald Küfe, Caining Jin, Maroof Alam, Ashujit Tagde and Hasan Rajabi and has published in prestigious journals such as Cancer Research, Applied Energy and Frontiers in Immunology.

In The Last Decade

Xiufeng Hu

22 papers receiving 802 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiufeng Hu China 15 522 333 214 145 139 23 807
Yingchen Xu China 16 475 0.9× 322 1.0× 144 0.7× 81 0.6× 83 0.6× 44 797
Guoxu Zheng China 15 421 0.8× 197 0.6× 209 1.0× 77 0.5× 215 1.5× 29 793
Xiaoguang Yu China 18 508 1.0× 261 0.8× 236 1.1× 105 0.7× 87 0.6× 36 827
Jia‐shun Wu China 17 395 0.8× 275 0.8× 253 1.2× 72 0.5× 145 1.0× 31 803
Junyi Hu China 16 499 1.0× 235 0.7× 330 1.5× 239 1.6× 242 1.7× 43 1.0k
Hua Duan China 12 578 1.1× 294 0.9× 158 0.7× 108 0.7× 151 1.1× 40 920
Ziwei Zeng China 14 434 0.8× 271 0.8× 235 1.1× 85 0.6× 125 0.9× 50 811
Yuhu Dai China 16 722 1.4× 472 1.4× 244 1.1× 164 1.1× 71 0.5× 24 1.1k
Shufang Jin China 19 507 1.0× 342 1.0× 189 0.9× 129 0.9× 119 0.9× 38 870
Yun Che China 21 752 1.4× 568 1.7× 349 1.6× 304 2.1× 163 1.2× 43 1.2k

Countries citing papers authored by Xiufeng Hu

Since Specialization
Citations

This map shows the geographic impact of Xiufeng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiufeng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiufeng Hu more than expected).

Fields of papers citing papers by Xiufeng Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiufeng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiufeng Hu. The network helps show where Xiufeng Hu may publish in the future.

Co-authorship network of co-authors of Xiufeng Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiufeng Hu. A scholar is included among the top collaborators of Xiufeng Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiufeng Hu. Xiufeng Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lü, Shun, Lunxu Liu, Rui Li, et al.. (2025). Efficacy and Safety of Atezolizumab in Chinese Patients With Advanced Thymic Carcinoma: A Multicenter, Single-Arm Phase 2 Study. Clinical Lung Cancer. 26(3). 244–252.e2.
2.
3.
Mu, Xiaoqian, et al.. (2024). Exosomal miR-1228-5p down-regulates DUSP22 to promotes cell proliferation and migration in small cell lung cancer. Life Sciences. 351. 122787–122787. 5 indexed citations
4.
5.
Gao, Fangfang, Xiufeng Hu, Wenjing Liu, et al.. (2022). Calcium-activated nucleotides 1 (CANT1)-driven nuclear factor-k-gene binding (NF-ĸB) signaling pathway facilitates the lung cancer progression. Bioengineered. 13(2). 3183–3193. 11 indexed citations
6.
Mu, Xiaoqian, Hongbo Wu, Jie Liu, et al.. (2020). Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p. Biomedicine & Pharmacotherapy. 125. 109989–109989. 30 indexed citations
7.
Wu, Hongbo, Xiaoqian Mu, Lei Liu, et al.. (2020). Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells via targeting LRRC1. Cell Death and Disease. 11(9). 801–801. 111 indexed citations
8.
Liu, Jie, Xiao Han, Lijuan Chen, et al.. (2020). <i>TRIM28</i> is a distinct prognostic biomarker that worsens the tumor immune microenvironment in lung adenocarcinoma. Aging. 12(20). 20308–20331. 18 indexed citations
9.
Hu, Xiufeng, Yu Mu, Jie Liu, et al.. (2020). Exosomes Derived from Hypoxic Colorectal Cancer Cells Transfer miR-410-3p to Regulate Tumor Progression. Journal of Cancer. 11(16). 4724–4735. 23 indexed citations
10.
Hu, Xiufeng, et al.. (2020). Case Report: PD-1 Inhibitor Is Active in Lung Adenocarcinoma With B Cell Deficiency. Frontiers in Immunology. 11. 563622–563622. 4 indexed citations
11.
Hu, Xiufeng, Huijuan Wu, Jie Liu, et al.. (2019). Unique profiles of targetable genomic alterations and prognosis in young Chinese patients with lung adenocarcinoma. Pathology - Research and Practice. 215(6). 152407–152407. 9 indexed citations
12.
Chen, Lijuan, Xiufeng Hu, Huijuan Wu, et al.. (2018). Over-expression of S100B protein as a serum marker of brain metastasis in non-small cell lung cancer and its prognostic value. Pathology - Research and Practice. 215(3). 427–432. 18 indexed citations
13.
Xu, Yuanlin, Xihong Zhang, Xiufeng Hu, et al.. (2018). The effects of lncRNA MALAT1 on proliferation, invasion and migration in colorectal cancer through regulating SOX9. Molecular Medicine. 24(1). 52–52. 111 indexed citations
14.
Maeda, Takahiro, Masayuki Hiraki, Caining Jin, et al.. (2017). MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer. Cancer Research. 78(1). 205–215. 183 indexed citations
15.
Wang, Hai‐Ling, Beibei Chen, Jin Wang, et al.. (2015). The clinical significances of the abnormal expressions of Piwil1 and Piwil2 in colonic adenoma and adenocarcinoma. OncoTargets and Therapy. 8. 1259–1259. 12 indexed citations
16.
Hu, Xiufeng, et al.. (2014). Midkine and syndecan-1 levels correlate with the progression of malignant gastric cardiac adenocarcinoma. Molecular Medicine Reports. 10(3). 1409–1415. 15 indexed citations
17.
Li, Xingya, Yanqiu Zhao, Ruiqing Liu, et al.. (2013). Genotype–phenotype correlation in Chinese patients with pulmonary mixed type adenocarcinoma: Relationship between histologic subtypes, TITF-1/SP-A expressions and EGFR mutations. Pathology - Research and Practice. 210(3). 176–181. 17 indexed citations
18.
Hu, Xiufeng, et al.. (2013). Nrf2 Overexpression Predicts Prognosis and 5-FU Resistance in Gastric Cancer. Asian Pacific Journal of Cancer Prevention. 14(9). 5231–5235. 78 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingchen Xu Breakdown of academic impact, for papers by Guoxu Zheng Breakdown of academic impact, for papers by Xiaoguang Yu Breakdown of academic impact, for papers by Jia‐shun Wu Breakdown of academic impact, for papers by Junyi Hu Breakdown of academic impact, for papers by Hua Duan Breakdown of academic impact, for papers by Ziwei Zeng Breakdown of academic impact, for papers by Yuhu Dai Breakdown of academic impact, for papers by Shufang Jin Breakdown of academic impact, for papers by Yun Che
Rankless by CCL
2026